Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:26 PM
What would change this read
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
TL;DR
Seed (YC)Novaflow - AI Bioinformatics Analysis AI-driven bioinformatics analysis without coding.
Raised $500K across 1 funding round. Latest: $500K Seed (Jul 2025). Investors: Y Combinator. (High).
Funding
Raised $500K across 1 funding round. Latest: $500K Seed (Jul 2025). Investors: Y Combinator. (High).
Product / news
1 product/news‑styled row(s); headline risk without filings (High).
Verified facts
YC S25; AI data analyst for biology labs turning raw data into publication-ready results.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
No open roles indexed yet.
The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.
Source types found
Strongest / recent news-style rows
Wed, May 20, 06:26 PM · confidence 88%high quality
Wed, May 20, 06:26 PM · confidence 85%medium quality
wikipedia · Mon, Jun 29, 01:04 AM · confidence 50%low quality
Newest first · 5 event(s)
Source: Homepage
Novaflow is an AI-driven bioinformatics tool that turns raw data into publication-ready results - no coding required. Built for researchers, labs, and life science teams.
YC S25; AI data analyst for biology labs turning raw data into publication-ready results.
YC launch on automating bioinformatics for researchers.
1 row(s)
The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.
Novaflow is an AI-driven bioinformatics tool that turns raw data into publication-ready results - no coding required. Built for researchers, labs, and life science teams.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗3 row(s)
Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.
YC launch on automating bioinformatics for researchers.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗1 row(s)
Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.
YC S25; AI data analyst for biology labs turning raw data into publication-ready results.
Why it matters: Funding signal — Seed per this source; verify against the linked original before relying on it.
Open source ↗Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.